The test for Hepatitis A Virus (HAV) IgM Antibodies, also known as “HAV IgM serology,” is a diagnostic procedure that finds IgM antibodies that are exclusive to the virus. These antibodies show evidence of a recent or acute hepatitis A virus infection. The infectious virus known as hepatitis A mostly affects the liver, causing symptoms like exhaustion, jaundice, and stomach pain.
The inclusion of “health heart diagnostics” (HHD) in the HAV IgM serology description highlights the significance of this test in overall health management, especially with regard to cardiovascular health. Although the liver is the primary target of hepatitis A, the overall effects of acute or chronic liver disease can have a substantial impact on cardiovascular health. Changes in the metabolism of lipids, cholesterol, and other molecules essential for heart health can result from severe liver infections.